《Cytopathology》雜志的收稿范圍和要求是什么?
來源:優(yōu)發(fā)表網(wǎng)整理 2024-09-18 10:56:30 171人看過
《Cytopathology》雜志收稿范圍涵蓋醫(yī)學(xué)全領(lǐng)域,此刊是該細(xì)分領(lǐng)域中屬于非常不錯的SCI期刊,在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大,專業(yè)度認(rèn)可很高,所以對原創(chuàng)文章要求創(chuàng)新性較高,如果您的文章質(zhì)量很高,可以嘗試。平均審稿速度 較慢,6-12周 ,或約稿 ,影響因子指數(shù)1.2,該期刊近期沒有被列入國際期刊預(yù)警名單,廣大學(xué)者值得一試。
具體收稿要求需聯(lián)系雜志社或者咨詢本站客服,在線客服團(tuán)隊(duì)會及時為您答疑解惑,提供針對性的建議和解決方案。
出版商聯(lián)系方式:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148
其他數(shù)據(jù)
是否OA開放訪問: | h-index: | 年文章數(shù): |
未開放 | 42 | 120 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
13.95% | 1.2 | 0.06... |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預(yù)警名單(試行)》名單: |
75.83% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年中科院JCR大類分區(qū)數(shù)據(jù):
歷年自引數(shù)據(jù):
發(fā)文統(tǒng)計(jì)
2023-2024國家/地區(qū)發(fā)文量統(tǒng)計(jì):
國家/地區(qū) | 數(shù)量 |
India | 121 |
USA | 53 |
Italy | 38 |
Japan | 38 |
England | 26 |
Brazil | 20 |
France | 15 |
Switzerland | 14 |
CHINA MAINLAND | 12 |
Spain | 12 |
2023-2024機(jī)構(gòu)發(fā)文量統(tǒng)計(jì):
機(jī)構(gòu) | 數(shù)量 |
POST GRADUATE INSTITUTE OF MEDIC... | 47 |
JAWAHARLAL INSTITUTE OF POSTGRAD... | 24 |
ALL INDIA INSTITUTE OF MEDICAL S... | 18 |
A.C.CAMARGO CANCER CENTER | 9 |
CATHOLIC UNIVERSITY OF THE SACRE... | 9 |
PENNSYLVANIA COMMONWEALTH SYSTEM... | 9 |
SANTA CASA MED SCH | 9 |
UNIVERSITA DELLA CAMPANIA VANVIT... | 8 |
KEPLER UNIVERSITY HOSPITAL | 7 |
HOSPITAL UNIVERSITARIO LA PAZ | 6 |
近年引用統(tǒng)計(jì):
期刊名稱 | 數(shù)量 |
CANCER CYTOPATHOL | 210 |
DIAGN CYTOPATHOL | 178 |
CYTOPATHOLOGY | 136 |
ACTA CYTOL | 94 |
AM J SURG PATHOL | 69 |
AM J CLIN PATHOL | 60 |
ARCH PATHOL LAB MED | 43 |
MODERN PATHOL | 40 |
BLOOD | 30 |
NEW ENGL J MED | 25 |
近年被引用統(tǒng)計(jì):
期刊名稱 | 數(shù)量 |
CYTOPATHOLOGY | 136 |
DIAGN CYTOPATHOL | 121 |
CANCER CYTOPATHOL | 58 |
ACTA CYTOL | 38 |
J CYTOL | 25 |
CANCERS | 15 |
FRONT ONCOL | 14 |
PLOS ONE | 12 |
VET CLIN PATH | 9 |
ARCH PATHOL LAB MED | 8 |
近年文章引用統(tǒng)計(jì):
文章名稱 | 數(shù)量 |
A retrospective 3-year study of ... | 18 |
The utility of the Milan System ... | 17 |
Cell blocks in cytopathology: An... | 15 |
Impact on clinical follow-up of ... | 12 |
Programmed death-ligand 1 immuno... | 10 |
The Paris System for urine cytol... | 8 |
Insulinoma-associated protein 1 ... | 8 |
A Combined test using both cell ... | 7 |
Diagnosis of anaplastic large ce... | 7 |
Thyroid FNAC: Causes of false-po... | 6 |